Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-02-01 Sale | 2024-02-02 9:35 pm | Cullinan Oncology Inc. | CGEM | Savill Corrine Chief Business Officer | 40,000 | $16.18 | $647,200 | 236,321 (Direct) | View |
| 2024-01-29 Sale | 2024-01-30 7:00 pm | Cullinan Oncology Inc. | CGEM | Savill Corrine Chief Business Officer | 40,000 | $14.09 | $563,600 | 276,321 (Direct) | View |
| 2024-01-22 Sale | 2024-01-24 5:00 pm | Cullinan Oncology Inc. | CGEM | Savill Corrine Chief Business Officer | 40,000 | $12.31 | $492,508 | 215,300 (Direct) | View |
| 2022-07-18 Sale | 2022-07-21 4:30 pm | Cullinan Oncology Inc. | CGEM | Savill Corrine Acting Chief Business Officer | 20,000 | $15.18 | $303,593 | 149,615 (Direct) | View |
| 2022-07-11 Sale | 2022-07-12 4:14 pm | Cullinan Oncology Inc. | CGEM | Savill Corrine Acting Chief Business Officer | 40,000 | $13.33 | $533,304 | 169,615 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-22 Option Award | 2024-02-23 5:00 pm | N/A 2034-02-22 | Cullinan Oncology Inc. | CGEM | Savill Corrine Chief Business Officer | 112,500 | $0 | 278,490 (Direct) | View |
| 2024-02-01 Exercise | 2024-02-02 9:35 pm | N/A N/A | Cullinan Oncology Inc. | CGEM | Savill Corrine Chief Business Officer | 40,000 | $4.3 | 236,321 (Direct) | View |
| 2024-02-01 Exercise | 2024-02-02 9:35 pm | N/A 2030-10-31 | Cullinan Oncology Inc. | CGEM | Savill Corrine Chief Business Officer | 40,000 | $0 | 236,321 (Direct) | View |
| 2024-01-29 Exercise | 2024-01-30 7:00 pm | N/A N/A | Cullinan Oncology Inc. | CGEM | Savill Corrine Chief Business Officer | 40,000 | $4.3 | 276,321 (Direct) | View |
| 2024-01-29 Exercise | 2024-01-30 7:00 pm | N/A 2030-10-28 | Cullinan Oncology Inc. | CGEM | Savill Corrine Chief Business Officer | 40,000 | $0 | 276,321 (Direct) | View |
| 2024-01-22 Exercise | 2024-01-24 5:00 pm | N/A N/A | Cullinan Oncology Inc. | CGEM | Savill Corrine Chief Business Officer | 35,875 | $4.3 | 215,300 (Direct) | View |
| 2024-01-22 Exercise | 2024-01-24 5:00 pm | N/A 2030-10-28 | Cullinan Oncology Inc. | CGEM | Savill Corrine Chief Business Officer | 35,875 | $0 | 215,300 (Direct) | View |
| 2023-02-17 Option Award | 2023-02-21 6:57 pm | N/A 2033-02-16 | Cullinan Oncology Inc. | CGEM | Savill Corrine Chief Business Officer | 61,500 | $0 | 211,115 (Direct) | View |
| 2022-02-11 Option Award | 2022-02-15 4:43 pm | N/A 2032-02-10 | Cullinan Oncology Inc. | CGEM | Savill Corrine Acting Chief Business Officer | 49,500 | $0 | 242,615 (Direct) | View |
Ownership | 2021-01-07 8:29 pm | N/A N/A | Cullinan Management Inc. | CGEM | Savill Corrine Acting Chief Business Officer | 0 | $0 | 379,321 (Direct) | View |